Loading clinical trials...
Loading clinical trials...
The main objective of this study is to validate the utility of IgE anti-cetuximab in the treatment strategy to identify patients at risk for a severe allergic reaction to cetuximab (grade 3 or 4 of th...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Centre Francois Baclesse
Collaborators
NCT07669519 · Fatigue, Colon Cancer
NCT05239546 · Colon Cancer, dMMR Colorectal Cancer
NCT05076760 · Solid Tumor, Advanced Cancer, and more
NCT06851663 · Solid Tumor, Solid Carcinoma, and more
NCT05884723 · Liver Steatoses, Liver Metastasis Colon Cancer, and more
CHU
Amiens
Centre hospitalier
Bayeux
CHU
Caen
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions